TY - JOUR
T1 - Impact of carcinomatosis and ascites status on long-term outcomes of palliative treatment for patients with gastric outlet obstruction caused by unresectable gastric cancer
T2 - Stent placement versus palliative gastrojejunostomy
AU - Park, Chan Hyuk
AU - Park, Jun Chul
AU - Kim, Eun Hye
AU - Chung, Hyunsoo
AU - An, Ji Yeong
AU - Kim, Hyoung Il
AU - Shin, Sung Kwan
AU - Lee, Sang Kil
AU - Cheong, Jae Ho
AU - Hyung, Woo Jin
AU - Lee, Yong Chan
AU - Noh, Sung Hoon
AU - Kim, Choong Bae
N1 - Publisher Copyright:
© 2015 American Society for Gastrointestinal Endoscopy.
PY - 2015/2/1
Y1 - 2015/2/1
N2 - Background Self-expandable metal stent (SEMS) placement and palliative gastrojejunostomy (GJJ) are palliative treatment options for malignant gastric outlet obstruction. Objective To compare clinical outcomes of palliative treatments for gastric outlet obstruction caused by unresectable gastric cancer. Design Retrospective study. Setting University-affiliated tertiary-care hospital in the Republic of Korea. Patients Two hundred fifty-six patients with gastric outlet obstruction caused by unresectable gastric cancer. Intervention SEMS placement and palliative GJJ. Main Outcome Measurements Patency duration and overall survival duration. Results In total, 217 and 39 patients underwent SEMS placement and palliative GJJ, respectively, as an initial palliative treatment. Treatment modality affected reobstruction after clinical success (hazard ratio [HR] [95% confidence interval {CI}], 0.5 [0.3-0.8] of palliative GJJ). In addition, carcinomatosis with ascites was an independent associated factor of clinical success and reobstruction (HR [95% CI], 0.3 [0.1-0.7] and 1.4 [1.0-2.0], respectively). In a subgroup of patients with good performance who had neither carcinomatosis nor ascites, patency duration and overall survival duration did not differ between the 2 groups (P =.079 and P =.290, respectively). In patients with good performance who had carcinomatosis without ascites, patency duration was longer in the palliative GJJ group than in the SEMS placement group (P =.016). Overall survival, however, did not differ between the 2 groups (P =.062). In a subgroup of patients with good performance who had carcinomatosis with ascites, both patency duration and overall survival were longer in the palliative GJJ group than in the SEMS placement group (P =.007 and P =.012, respectively). Limitations Nonrandomized, retrospective study. Conclusion Long-term clinical outcomes of the palliative treatment modality for gastric outlet obstruction caused by unresectable gastric cancer were affected by carcinomatosis and ascites status.
AB - Background Self-expandable metal stent (SEMS) placement and palliative gastrojejunostomy (GJJ) are palliative treatment options for malignant gastric outlet obstruction. Objective To compare clinical outcomes of palliative treatments for gastric outlet obstruction caused by unresectable gastric cancer. Design Retrospective study. Setting University-affiliated tertiary-care hospital in the Republic of Korea. Patients Two hundred fifty-six patients with gastric outlet obstruction caused by unresectable gastric cancer. Intervention SEMS placement and palliative GJJ. Main Outcome Measurements Patency duration and overall survival duration. Results In total, 217 and 39 patients underwent SEMS placement and palliative GJJ, respectively, as an initial palliative treatment. Treatment modality affected reobstruction after clinical success (hazard ratio [HR] [95% confidence interval {CI}], 0.5 [0.3-0.8] of palliative GJJ). In addition, carcinomatosis with ascites was an independent associated factor of clinical success and reobstruction (HR [95% CI], 0.3 [0.1-0.7] and 1.4 [1.0-2.0], respectively). In a subgroup of patients with good performance who had neither carcinomatosis nor ascites, patency duration and overall survival duration did not differ between the 2 groups (P =.079 and P =.290, respectively). In patients with good performance who had carcinomatosis without ascites, patency duration was longer in the palliative GJJ group than in the SEMS placement group (P =.016). Overall survival, however, did not differ between the 2 groups (P =.062). In a subgroup of patients with good performance who had carcinomatosis with ascites, both patency duration and overall survival were longer in the palliative GJJ group than in the SEMS placement group (P =.007 and P =.012, respectively). Limitations Nonrandomized, retrospective study. Conclusion Long-term clinical outcomes of the palliative treatment modality for gastric outlet obstruction caused by unresectable gastric cancer were affected by carcinomatosis and ascites status.
UR - http://www.scopus.com/inward/record.url?scp=84921543338&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84921543338&partnerID=8YFLogxK
U2 - 10.1016/j.gie.2014.06.024
DO - 10.1016/j.gie.2014.06.024
M3 - Article
C2 - 25085332
AN - SCOPUS:84921543338
SN - 0016-5107
VL - 81
SP - 321
EP - 332
JO - Gastrointestinal Endoscopy
JF - Gastrointestinal Endoscopy
IS - 2
ER -
